维普中文期刊产品整合服务
15篇 您的检索式:作者名="KEMPER MK"
    题名 作者 年代 出处 被引量
1The timing of normalization of GA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,2:1
2Chemotherapy re- lated myelesuppression a, Samarker of survival in epithelial ovariancancer patients显示文摘Rocconi RP Matthows KS Kemper MK 2008Gynecol Oncol2008,108,2:1
3The timing ofnormalization of CA-125 levels during primary chemotherapy ispredictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,:1
4Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients 显示文摘ROCCONI R P MATTHEWS KS KEMPER MK 2008Gynecol Orwol2008,108,2:1
5Chemotherapy related myelosuppression as a marker of survival in epithelial ovarian cancer patients显示文摘Rocconi RP Mattews KS Kemper MK 2007Gynecol Oncol2007,104,1:1
6The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,:1
7The timing of normalization of CA 125 levels during primary chemo - therapy is predictive of sur- vival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,2:1
8The timing of normalization of CA-125 levels during primary chemother- apy is predictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,2:1
9The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer 显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,:1
10The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,2:1
11Chemotherapy-related myelosuppression as a marker of survival inepithelial ovarian cancer patients 显示文摘Rocconi RP Matthews KS Kemper MK 2008Gynecol Oncol2008,108,2:1
12The timing of normalization of CA 125 levels during primary chemo- therapy is predictive of survival in patients with epithelial ovarian cancer显示文摘Rocconi RP Matthews KS Kemper MK 2009Gynecol Oncol2009,114,2:1
13The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer 显示文摘Roeeoni RP Matthews KS Kemper MK 2009Gyneeol Oneol2009,114,2:1
14Emerging roles and new functions of CD46显示文摘Liszewski MK Kemper C Price JD 2005Springer Semin Immunopathol2005,27,3:1
15Chemotherapy related myelosuppression as a marker of survival in epithelial ovarian cancer patients显示文摘Rocconi RP Mattews KS Kemper MK 2007Gynecol Oncol2007,104,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费